Provided by Tiger Fintech (Singapore) Pte. Ltd.

Unicycive Therapeutics, Inc.

0.6379
+0.00801.27%
Post-market: 0.6350-0.0029-0.45%19:58 EDT
Volume:4.19M
Turnover:2.63M
Market Cap:76.95M
PE:-2.45
High:0.6600
Open:0.6500
Low:0.6008
Close:0.6299
Loading ...
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Major Issues Report

8-K - Current report
Jul 18, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 15, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Major Issues Report

8-K - Current report
Sep 23, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933